2. Pfizer leads in terms of followers despite a late start; GSKUS most
impresssive growth (77% vs 51% on average)
# of Followers
2 699
1 313
Avg Dec 09
Avg Jul 09
Source: www.twi-er.com, July 13th and Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
3. Great divide on following policy amongst pharma twitter accounts –
question of “social media maturity“?
# of Following
600
392
Avg Dec 09
Avg Jul 09
Source: www.twi-er.com, July 13th and Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
4. Great divide also on activity – indicator for degree of engagement?
# of Updates
255
119
Avg Dec 09
Avg Jul 09
Source: www.twi-er.com, July 13th and Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
5. Boehringer and JNJ track above average in terms of engagement
# of Following
The twitter engagement
quardrant: above
average followers,
following and updates!
Average following: 392
Average Updates: 119 # of Updates
Bubble size = # of followers
Source: www.twi-er.com, July 13th and Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
6. ... Roche and AstraZeneca moving into the “engagement“ quardrant
# of Following
@Pfizer_news
Avrg following: 600
@genentechnews
Avrg Updates: 255 # of Updates
Avrg Bubble size = # of followers
Source: www.twi-er.com, July 13th and Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
7. 26% of Boehringer followers are large accounts (>500 followers) vs. only
14% for Novartis - less is more?
Number of % with >500
followers followers
3 941 15%
3 865 14%
3 304 26%
2 780 20%
2 574 20%
Avrg 19%
Number of followers that
are followed by
19% of pharma followers (roughly 3000 accounts) are large accounts (>500 followers).
The segmentation and profiling of these accounts, will be the basis of Part II of this analysis.
Source: www.twi-er.com, Dec 31st 2009; whdotpharma analysis
jeudi, 21 janvier 2010
8. Coming to whydotpharma soon:
the mapping of the pharma twittersphere!
Stay tuned!
jeudi, 21 janvier 2010